{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:55:18Z","timestamp":1769766918303,"version":"3.49.0"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81804158"],"award-info":[{"award-number":["81804158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The aim of this study was to investigate the mechanism of action of SB on TRP-induced abnormalities of bone metabolism in LNCaP cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The effects of different concentrations of SB and TRP alone and in combination on the proliferation of LNCaP cells were examined by CCK-8 assay, and the half maximal inhibitory concentration were screened for the subsequent experiments. Transwell migration and invasion assays were used to further investigate the effects of SB and TRP alone and in combination on the migration and invasion ability of LNCaP cells. Based on Tandem Mass Tag (TMT) labeling and liquid chromatography-tandem mass spectrometry (LC-MS\/MS) technology, the differentially expressed proteins (DEPs) of LNCaP cells in the control group, SB group, TRP group and combination group were quantified. Bioinformatics technology was used to analyze the DEPs of LNCaP cells in each group. At last, the achieved key targets were verified by western blot.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The inhibitory effects of different concentrations of SB and TRP alone and in combination on the proliferation, migration and invasion of LNCaP cells showed both time-dependent and concentration-dependent effects, and the inhibitory effects of the combination of drugs on LNCaP cells were more significant. The proteomics results showed that a total of 153 DEPs were identified in the SB group and the control group, 100 DEPs were identified in the TRP group and the control group, and 524 DEPs were identified in the combination group and the control group.<\/jats:p>\n                    <jats:p>Bioinformatics analysis showed that a higher number of DEPs were enriched in the IL-17 signaling pathway in the SB and combined treatment groups compared to the control group. These findings suggest a potential role of SB and the combined treatment in modulating the IL-17 signaling pathway. In contrast, the same DEPs were found to be enriched in both the Circadian entrainment and Apelin signaling pathways in the TRP versus control and combined treatment versus control comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SB may regulate TRP-induced bone metabolism abnormalities in LNCaP cells through the IL-17 signaling pathway as well as five DEPs: p-ERK2, RELA, HSP90B1, GNAI1and GNAI3.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0341064","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:24:37Z","timestamp":1769711077000},"page":"e0341064","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of silybin on triptorelin-induced bone metabolic abnormalities in prostate cancer revealed based on TMT-based proteomics"],"prefix":"10.1371","volume":"21","author":[{"given":"Jianhui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejiao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4532-9497","authenticated-orcid":true,"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"1","key":"pone.0341064.ref001","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/14756366.2021.2018684","article-title":"Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells","volume":"37","author":"X Wang","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"pone.0341064.ref002","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"RL Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"pone.0341064.ref003","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/bjc.2016.304","article-title":"Cancer incidence and mortality projections in the UK until 2035","volume":"115","author":"CR Smittenaar","year":"2016","journal-title":"Br J Cancer"},{"issue":"3","key":"pone.0341064.ref004","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"RL Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"pone.0341064.ref005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2022.2123675","article-title":"Suppressive function of bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-187 in prostate cancer","volume":"23","author":"C Li","year":"2022","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"pone.0341064.ref006","first-page":"228","article-title":"The risk factors of prostate cancer and its prevention: a literature review","volume":"48","author":"NR Perdana","year":"2016","journal-title":"Acta Med Indones"},{"issue":"12","key":"pone.0341064.ref007","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/ijc.34223","article-title":"Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry-based metabolomics: A case-control study nested in the Northern Sweden Health and Disease Study","volume":"151","author":"JR \u00d6stman","year":"2022","journal-title":"Int J Cancer"},{"issue":"6","key":"pone.0341064.ref008","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and Prevention of Prostate Cancer","volume":"4","author":"G Gandaglia","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"pone.0341064.ref009","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.eururo.2014.09.049","article-title":"Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level","volume":"67","author":"T Karantanos","year":"2015","journal-title":"Eur Urol"},{"key":"pone.0341064.ref010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ctrv.2018.11.005","article-title":"Management of advanced prostate cancer: A systematic review of existing guidelines and recommendations","volume":"73","author":"A Dellis","year":"2019","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"pone.0341064.ref011","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4143\/crt.2021.985","article-title":"Optimal definition of biochemical recurrence in patients who receive salvage radiotherapy following radical prostatectomy for prostate cancer","volume":"54","author":"SU Lee","year":"2022","journal-title":"Cancer Res Treat"},{"issue":"12","key":"pone.0341064.ref012","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1007\/s11136-022-03202-2","article-title":"Health-related quality of life in long-term Caribbean prostate cancer survivors: comparisons with prostate cancer-free men","volume":"31","author":"MD Jackson","year":"2022","journal-title":"Qual Life Res"},{"issue":"11","key":"pone.0341064.ref013","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-17-1051","article-title":"Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGF\u03b2RIII-p38MAPK-pS249\/T252RB pathway","volume":"78","author":"L-Y Yu-Lee","year":"2018","journal-title":"Cancer Res"},{"key":"pone.0341064.ref014","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-3-030-32656-2_9","article-title":"The bone microenvironment in prostate cancer metastasis","volume":"1210","author":"A DiNatale","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"pone.0341064.ref015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40880-019-0425-1","article-title":"Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer","volume":"39","author":"X Zhang","year":"2019","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"pone.0341064.ref016","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13046-023-02610-7","article-title":"Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer","volume":"42","author":"D Kong","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"pone.0341064.ref017","doi-asserted-by":"crossref","first-page":"574394","DOI":"10.3389\/fcell.2020.574394","article-title":"Silybin prevents prostate cancer by inhibited the ALDH1A1 expression in the retinol metabolism pathway","volume":"8","author":"Y Jiang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"pone.0341064.ref018","doi-asserted-by":"crossref","first-page":"113303","DOI":"10.1016\/j.jep.2020.113303","article-title":"The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and clinical evidence","volume":"265","author":"I Marmouzi","year":"2021","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"pone.0341064.ref019","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1080\/17512433.2016.1208563","article-title":"Silibinin: a potential old drug for cancer therapy","volume":"9","author":"X-X Zhu","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"pone.0341064.ref020","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1208\/s12248-013-9486-2","article-title":"Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer","volume":"15","author":"H Ting","year":"2013","journal-title":"AAPS J"},{"key":"pone.0341064.ref021","first-page":"963689720950213","article-title":"Silibinin promotes cell proliferation through facilitating G1\/S transitions by activating Drp1-mediated mitochondrial fission in cells","volume":"29","author":"Y You","year":"2020","journal-title":"Cell Transplant"},{"issue":"8","key":"pone.0341064.ref022","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/pros.21118","article-title":"A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer","volume":"70","author":"TW Flaig","year":"2010","journal-title":"Prostate"},{"issue":"3","key":"pone.0341064.ref023","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10059-009-0123-y","article-title":"Silibinin inhibits osteoclast differentiation mediated by TNF family members","volume":"28","author":"JH Kim","year":"2009","journal-title":"Mol Cells"},{"issue":"7","key":"pone.0341064.ref024","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s12325-016-0351-4","article-title":"An update on triptorelin: current thinking on androgen deprivation therapy for prostate cancer","volume":"33","author":"AS Merseburger","year":"2016","journal-title":"Adv Ther"},{"key":"pone.0341064.ref025","doi-asserted-by":"crossref","DOI":"10.4103\/ijc.IJC_65_21","article-title":"Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety","volume":"59","author":"T Raja","year":"2022","journal-title":"Indian J Cancer"},{"key":"pone.0341064.ref026","doi-asserted-by":"crossref","first-page":"968485","DOI":"10.3389\/fped.2022.968485","article-title":"Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States","volume":"10","author":"J Popovic","year":"2022","journal-title":"Front Pediatr"},{"issue":"5","key":"pone.0341064.ref027","article-title":"The efficacy and safety of triptorelin-therapy following conservative surgery for deep infiltrating endometriosis: A multicenter, prospective, non-interventional study in China","volume":"101","author":"L Zhu","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"pone.0341064.ref028","volume-title":"LiveTox: Clinical and Reseaech information on Drug-induced Liver injury","author":"Gonadotropin Releasing Hormone (GnRH) Analogues","year":"2012"},{"issue":"2","key":"pone.0341064.ref029","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12325-016-0466-7","article-title":"Efficacy of testosterone suppression with sustained-release triptorelin in advanced prostate cancer","volume":"34","author":"J Breul","year":"2017","journal-title":"Adv Ther"},{"key":"pone.0341064.ref030","volume-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2012"},{"issue":"4","key":"pone.0341064.ref031","first-page":"10738","article-title":"Decreased testosterone recovery after androgen deprivation therapy for prostate cancer","volume":"28","author":"ME Long","year":"2021","journal-title":"Can J Urol"},{"issue":"1","key":"pone.0341064.ref032","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/fon.12.158","article-title":"Triptorelin in the management of prostate cancer","volume":"9","author":"G Ploussard","year":"2012","journal-title":"Future Oncol"},{"issue":"4","key":"pone.0341064.ref033","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4111\/icu.2019.60.4.244","article-title":"Effectiveness of three different luteinizing hormone-releasing hormone agonists in the chemical castration of patients with prostate cancer: Goserelin versus triptorelin versus leuprolide","volume":"60","author":"M Shim","year":"2019","journal-title":"Investig Clin Urol"},{"issue":"4","key":"pone.0341064.ref034","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4161\/cbt.6.4.3891","article-title":"Phenoxodiol-Topotecan co-administration exhibit significant anti-tumor activity without major adverse side effects","volume":"6","author":"AB Alvero","year":"2007","journal-title":"Cancer Biol Ther"},{"issue":"9","key":"pone.0341064.ref035","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/cancers11091390","article-title":"Docetaxel Combined with thymoquinone induces apoptosis in prostate cancer cells via inhibition of the PI3K\/AKT signaling pathway","volume":"11","author":"SK Singh","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"8","key":"pone.0341064.ref036","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1248\/bpb.b17-00077","article-title":"Mechanistic study of inhibitory effects of metformin and atorvastatin in combination on prostate cancer cells in vitro and in vivo","volume":"40","author":"Z-S Wang","year":"2017","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"pone.0341064.ref037","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/ijms18020399","article-title":"The effect of metformin and GANT61 combinations on the radiosensitivity of prostate cancer cells","volume":"18","author":"A Gonnissen","year":"2017","journal-title":"Int J Mol Sci"},{"key":"pone.0341064.ref038","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-06-0846","article-title":"Treatment-related osteoporosis in men with prostate cancer","volume":"12","author":"MR Smith","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"8","key":"pone.0341064.ref039","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/cncr.21381","article-title":"Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma","volume":"104","author":"H Lee","year":"2005","journal-title":"Cancer"},{"key":"pone.0341064.ref040","doi-asserted-by":"crossref","first-page":"39562","DOI":"10.1038\/srep39562","article-title":"Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study","volume":"7","author":"SH Kim","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0341064.ref041","doi-asserted-by":"crossref","first-page":"110168","DOI":"10.1016\/j.cbi.2022.110168","article-title":"Silymarin prevents iron overload induced bone loss by inhibiting oxidative stress in an ovariectomized animal model","volume":"366","author":"Z-S Tao","year":"2022","journal-title":"Chem Biol Interact"},{"issue":"7","key":"pone.0341064.ref042","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/JPER.22-0535","article-title":"Silibinin alleviates inflammation-induced bone loss by modulating biological interaction between human gingival fibroblasts and monocytes","volume":"94","author":"R-Y Huang","year":"2023","journal-title":"J Periodontol"},{"key":"pone.0341064.ref043","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2013.09.031","article-title":"Silibinin promotes osteoblast differentiation of human bone marrow stromal cells via bone morphogenetic protein signaling","volume":"721","author":"X Ying","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"pone.0341064.ref044","doi-asserted-by":"crossref","first-page":"13413","DOI":"10.1002\/jcb.28616","article-title":"Modulatory effects of silibinin in cell behavior during osteogenic phenotype","volume":"120","author":"CJ da C Fernandes","year":"2019","journal-title":"J Cell Biochem"},{"key":"pone.0341064.ref045","first-page":"3829434","article-title":"Integrated Strategy of UHPLC-Q-TOF-MS and molecular networking for identification of diterpenoids from euphorbia fischeriana steud. and prediction of the anti-breast-cancer mechanism by the network pharmacological method","volume":"2021","author":"T-C Ma","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"pone.0341064.ref046","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/03008207.2020.1759562","article-title":"RANKL expression of primary osteoblasts is enhanced by an IL-17-mediated JAK2\/STAT3 pathway through autophagy suppression","volume":"62","author":"Z Wang","year":"2020","journal-title":"Connective Tissue Research"},{"issue":"7","key":"pone.0341064.ref047","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nri2998","article-title":"Expanding TRAF function: TRAF3 as a tri-faced immune regulator","volume":"11","author":"H H\u00e4cker","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"pone.0341064.ref048","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1172\/JCI66947","article-title":"Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation","volume":"124","author":"Y Xiu","year":"2014","journal-title":"J Clin Invest"},{"issue":"3","key":"pone.0341064.ref049","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbrc.2018.02.164","article-title":"IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro","volume":"497","author":"D Ke","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"pone.0341064.ref050","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbrc.2018.12.029","article-title":"IL-17A modulates osteoclast precursors\u2019 apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis","volume":"508","author":"Y Xue","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"pone.0341064.ref051","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3892\/etm.2021.10486","article-title":"IL-17F promotes osteoblastic osteogenesis via the MAPK\/ERK1\/2 signaling pathway","volume":"22","author":"N Zhang","year":"2021","journal-title":"Exp Ther Med"},{"key":"pone.0341064.ref052","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation","volume":"11","author":"S Giridharan","year":"2018","journal-title":"J Inflamm Res"},{"issue":"28","key":"pone.0341064.ref053","doi-asserted-by":"crossref","first-page":"24726","DOI":"10.1074\/jbc.M110.175364","article-title":"Nuclear factor-kappaB (NF-kappaB) p65 interacts with Stat5b in growth plate chondrocytes and mediates the effects of growth hormone on chondrogenesis and on the expression of insulin-like growth factor-1 and bone morphogenetic protein-2","volume":"286","author":"S Wu","year":"2011","journal-title":"J Biol Chem"},{"issue":"6","key":"pone.0341064.ref054","doi-asserted-by":"crossref","first-page":"190360","DOI":"10.1098\/rsos.190360","article-title":"Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-\u03baB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts","volume":"6","author":"L Yan","year":"2019","journal-title":"R Soc Open Sci"},{"key":"pone.0341064.ref055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gene.2018.06.068","article-title":"Scutellarin enhances osteoblast proliferation and function via NF-\u03baB-mediated CXCR4 induction","volume":"676","author":"J Wang","year":"2018","journal-title":"Gene"},{"issue":"26","key":"pone.0341064.ref056","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1182\/blood-2011-01-330464","article-title":"Heat-shock protein gp96\/grp94 is an essential chaperone for the platelet glycoprotein Ib-IX-V complex","volume":"117","author":"M Staron","year":"2011","journal-title":"Blood"},{"issue":"1","key":"pone.0341064.ref057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169260","article-title":"Mapping the Interactome of a Major Mammalian Endoplasmic Reticulum Heat Shock Protein 90","volume":"12","author":"F Hong","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"pone.0341064.ref058","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2009.080758","article-title":"Wnt signaling, lgr5, and stem cells in the intestine and skin","volume":"174","author":"A Haegebarth","year":"2009","journal-title":"Am J Pathol"},{"issue":"17","key":"pone.0341064.ref059","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1073\/pnas.1302933110","article-title":"Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway","volume":"110","author":"B Liu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0341064.ref060","doi-asserted-by":"crossref","first-page":"110438","DOI":"10.1016\/j.cellsig.2022.110438","article-title":"FOXO1 differentially regulates bone formation in young and aged mice","volume":"99","author":"Y Xiong","year":"2022","journal-title":"Cell Signal"},{"issue":"6","key":"pone.0341064.ref061","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/med.21915","article-title":"The biology and inhibition of glucose-regulated protein 94\/gp96","volume":"42","author":"KW Pugh","year":"2022","journal-title":"Med Res Rev"},{"key":"pone.0341064.ref062","doi-asserted-by":"crossref","first-page":"101972","DOI":"10.1016\/j.scr.2020.101972","article-title":"Calreticulin regulates Src kinase in osteogenic differentiation from embryonic stem cells","volume":"48","author":"Z Alvandi","year":"2020","journal-title":"Stem Cell Res"},{"issue":"8","key":"pone.0341064.ref063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011925","article-title":"Calcineurin interacts with PERK and dephosphorylates calnexin to relieve ER stress in mammals and frogs","volume":"5","author":"M Bollo","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"pone.0341064.ref064","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/jor.23587","article-title":"Calreticulin inhibits inflammation-induced osteoclastogenesis and bone resorption","volume":"35","author":"CR Fischer","year":"2017","journal-title":"J Orthop Res"},{"issue":"3","key":"pone.0341064.ref065","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2009.07.047","article-title":"CRELD2 is a novel endoplasmic reticulum stress-inducible gene","volume":"387","author":"K Oh-hashi","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"pone.0341064.ref066","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/jbmr.4010","article-title":"CRELD2 Is a Novel LRP1 chaperone that regulates noncanonical wnt signaling in skeletal development","volume":"35","author":"EP Dennis","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"1","key":"pone.0341064.ref067","doi-asserted-by":"crossref","first-page":"13884","DOI":"10.1038\/s41598-022-17347-0","article-title":"CRELD2 is a novel modulator of calcium release and calcineurin-NFAT signalling during osteoclast differentiation","volume":"12","author":"A Duxfield","year":"2022","journal-title":"Sci Rep"},{"key":"pone.0341064.ref068","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fonc.2015.00023","article-title":"Impacts of activation of the mitogen-activated protein kinase pathway in pancreatic cancer","volume":"5","author":"T Furukawa","year":"2015","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0341064.ref069","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008334","article-title":"Development of the endochondral skeleton","volume":"5","author":"F Long","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"pone.0341064.ref070","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jbmr.2409","article-title":"ERK1 and ERK2 regulate chondrocyte terminal differentiation during endochondral bone formation","volume":"30","author":"Z Chen","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"21","key":"pone.0341064.ref071","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1128\/MCB.01549-08","article-title":"Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis","volume":"29","author":"T Matsushita","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"52","key":"pone.0341064.ref072","doi-asserted-by":"crossref","first-page":"21366","DOI":"10.1073\/pnas.1219810110","article-title":"Development of the mammalian axial skeleton requires signaling through the G\u03b1(i) subfamily of heterotrimeric G proteins","volume":"109","author":"NW Plummer","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pone.0341064.ref073","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2741\/3656","article-title":"G Protein and its signaling pathway in bone development and disease","volume":"15","author":"M Wu","year":"2010","journal-title":"Front Biosci (Landmark Ed)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:24:49Z","timestamp":1769711089000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341064"}},"subtitle":[],"editor":[{"given":"Sudarshan","family":"Kasireddy","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0341064","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}